SimX Launches Scenario Editor, a No-Code Tool for Customizing VR Medical Simulations
SimX Launches Scenario Editor, a No-Code Tool for Customizing VR Medical Simulations
PR Newswire
SAN FRANCISCO, July 23, 2026
Facilitators can now edit patient dialogue, EHR screens, medication formularies, and learning objectives directly.
SAN FRANCISCO, July 23, 2026 /PRNewswire/ -- SimX, the global leader in virtual reality (VR) simulation for healthcare education and training, has launched Scenario Editor, a no-code platform that lets simulation facilitators adapt VR training scenarios to their institution's own clinical protocols, electronic health record systems, and medical formularies. The tool runs in a standard web browser and requires no coding.
Scenario Editor addresses a persistent pain point in clinical simulation: the gap between highly polished, professionally built VR content and the specific clinical realities of the institution using it. Until now, facilitators needing to update patient dialogue, swap EHR screenshots, or adjust assessed competencies had to submit a vendor request and wait. Scenario Editor eliminates that bottleneck.
"Scenario Editor was built around a simple conviction: the educators closest to the learners should have the power to shape the learning experience. We spent months listening to simulation faculty describe the workarounds they'd invented just to make their scenarios feel real for their students. This tool is our answer to every one of those workarounds, built to be genuinely usable by anyone on a simulation team, regardless of their technical background," said Sarah Davis, Product Manager at SimX.
Accessible from any web browser, Scenario Editor offers eight core capabilities:
- Custom patient and NPC dialogue: Edit how patients and care team characters respond.
- AI-generated audio: New dialogue is voiced automatically, typically within hours.
- Custom EMR slide uploads: Upload screenshots matching the institution's own EHR system, including Epic and Cerner.
- Editable critical action tracking: Align assessed competencies to the institution's curriculum and accreditation requirements.
- Pyxis medication customization: Stock the virtual Pyxis with the institution's actual medication formulary.
- Editable learning objectives: Adjust objectives per cohort.
- Non-destructive versioning: Every edit is saved as a new version; the original scenario is preserved.
- AI Assistant compatibility: Customized scenarios work with SimX AI Assistant without additional setup.
"Simulation only works when learners believe what they're seeing. The moment a patient responds with something that doesn't match their institution's protocol, or a lab value reflects someone else's EHR, the clinical reality breaks down, and the learning breaks down with it. Scenario Editor closes that gap at the source, enabling educators to ensure every detail of a scenario matches the clinical environment their learners are preparing for," said Jen Polson, Head of Product at SimX.
Scenario Editor further extends SimX's growing platform of tools and capabilities designed to help simulation programs run more, reach more learners, and deliver richer training experiences without asking more of their faculty.
About SimX
SimX is a leading provider of immersive VR simulation for healthcare education and training. Its platform is used by medical schools, nursing programs, healthcare systems, and government organizations worldwide to improve competency, enhance patient safety, and expand access to simulation-based learning.
Media Contact:
Jayne Michalek, Director of Marketing
419221@email4pr.com, (650) 231-5406
SOURCE SimX
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
The Smartest Moves for Bond Investors Today, and What to Do When You Have Too Many Investments
5 Stocks to Sell for Tax-Loss Harvesting
33 Undervalued Stocks to Buy Before the Market Shifts Again
Undervalued by 15%, This Utilities Stock Could Be an Unexpected AI Winner
United States